Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

BCMA and CD3 bispecific T cell engaging antibody constructs

US Patent 10301391 · Granted May 28, 2019

Estimated economic value: $208,028,000

Assignee

Inventors

View full patent text on Google Patents →